[1]
G. Yee, R. Wu, T. Ishikawa, and K. Takabe, “Invasive Lobular Carcinoma Has Higher Immune Response Than Invasive Ductal Carcinoma in Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Breast Cancers”, World J Oncol, vol. 16, no. 5, pp. 446–456, Sep. 2025, doi: 10.14740/wjon2529.